Yu Deng

Dr. Yu Deng

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2023 in Virology Journal
Verified
Journal Article
Open access
PDF file
XLXin Long
Xin Long
JXJun Xie
Jun Xie
LRLuo Ren
Luo Ren
GYGuangyuan Yu
Guangyuan Yu
ELEnmei Liu
Enmei Liu
XLXiaoru Long
Xiaoru Long
Background: IL-17A is a pleiotropic cytokine and intimately associated with asthma, but its role in respiratory syncytial virus (RSV) infection is conflicting in the literature. Methods: Children hospitalized in the respiratory department with RSV infection during RSV pandemic season of 2018–2020 were included. Nasopharyngeal aspirates were collected for pathogen and cytokines determination. In the murine model, RSV intranasal administrations were performed in wild-type and IL-17A-/- mice. Leukocytes and cytokines in bronchoalveolar lavage fluid (BALF), lung histopathology, and airway hyperresponsiveness (AHR) were measured. RORγt mRNA and IL-23R mRNA were semi-quantified by qPCR. Results: IL-17A increased significantly in RSV-infected children and was positively associated with pneumonia severity. In the murine model, IL-17A significantly increased in BALF of mice with RSV infection. Airway inflammation, lung tissue damage and AHR were significantly alleviated in wild-type mice following IL-17A neutralization and in the IL-17A-/- mice. IL-17A decreased by removing CD4+ T cells but increased by depleting CD8+ T cells. IL-6, IL-21, RORγt mRNA and IL-23R mRNA dramatically increased in parallel with the rise of IL-17A. Conclusions: IL-17A contributes to the airway dysfunctions induced by RSV in children and murine. CD3+CD4+T cells are its major cellular sources and the IL-6/IL-21-IL-23R-RORγt signaling pathway might participate in its regulation.

14 June 2024 in Journal of Medical Virology
Verified
Journal Article
Open access
PSPeiru Shi
Peiru Shi
RWRong Wang
Rong Wang
ELEnmei Liu
Enmei Liu
YDYu Deng
Yu Deng
This study aimed to determine the timing patterns of the initial respiratory syncytial virus (RSV) infection and to identify the factors influencing disease severity in infants of varying health status. A retrospective study was conducted at the Affiliated Children's Hospital of Chongqing Medical University from 2012 to 2022. The timing of the first RSV infection was estimated in infants with differing health status using correlation analysis, considering their birth time. Logistic regression was utilized to identify factors influencing severe RSV infection in these infants. RSV detection primarily occurred in the winter and spring. Epidemic season and peak timing of RSV were not significantly affected by health status or the COVID‐19 pandemic. A strong positive correlation was observed between the age at RSV infection and the interval from birth to the RSV peak season. Infants born during the RSV epidemic season exhibited a higher likelihood of infection within the first 2 months postbirth. In contrast, those born outside the RSV epidemic season were more susceptible to infection during the subsequent peak. Notably, infants with pre‐existing health conditions contracted RSV at an earlier age compared to their healthy counterparts. Among healthy infants, severe RSV infection was associated with sex, age, and timing of infection. For infants with underlying conditions, severe RSV infection was primarily related to age and timing of infection. The initial timing of RSV infection in infants varied depending on their health status. Young age and infection timing during the RSV epidemic season were significant risk factors for severe RSV infection. These findings provide a theoretical basis for optimizing immunization strategies for infants with diverse health conditions.

15 July 2025 in Pediatric Pulmonology
Verified
Journal Article
Open access
XLXin Long
Xin Long
WLWanling Li
Wanling Li
YTYuyi Tang
Yuyi Tang
ZLZhengxiu Luo
Zhengxiu Luo
JLJian Luo
Jian Luo
YDYu Deng
Yu Deng
Background: Pneumonia remains a leading cause of mortality among children under 5 years of age. This study aimed to compare existing prognostic scoring systems and identify the most effective tool for assessing outcomes in children with community‐acquired pneumonia (CAP). Methods: The Predisposition, Insult, Response, and Organ Dysfunction score for CAP (PIRO‐CAP) was modified to create the Ch‐online PIRO score based on a comprehensive cohort study. This new scoring system was validated in a cohort of 75,965 children under the age of 5 years with CAP, treated at the Children's Hospital of Chongqing Medical University between 2016 and 2021. Effectiveness in predicting severe cases was then compared against the Pediatric Critical Illness Score (PCIS), Pneumonia Etiology Research for Child Health (PERCH) score, and PIRO‐CAP score. Results: The Ch‐online PIRO score retained most of the original PIRO‐CAP factors, including age under 6 months, comorbidities, SpO 2 below 90%, multilobar or complicated pneumonia, kidney or liver dysfunction, and respiratory failure, but replaced hypotension and bacteremia with delayed capillary refill time (> 3 s) and procalcitonin > 0.5 ng/mL. When predicting severe CAP cases, the Ch‐online PIRO score demonstrated superior discriminatory performance (AUC = 0.85, 95% CI: 0.85–0.86) compared to the PCIS (AUC = 0.67, 95% CI: 0.66–0.69), PERCH score (AUC = 0.64, 95% CI: 0.64–0.65), and PIRO‐CAP score (AUC = 0.68, 95% CI: 0.64–0.71). Conclusion: The Ch‐online PIRO score shows promise as an effective prognostic tool for assessing the severity of CAP in young children.

10 May 2025 in Pediatric Discovery
Verified
Journal Article
Open access
YZYuanyuan Zhang
Yuanyuan Zhang
FYFuping Yang
Fuping Yang
CYChunyu Yan
Chunyu Yan
YDYu Deng
Yu Deng
ELEnmei Liu
Enmei Liu
Asthma, chronic pulmonary obstructive disease (COPD), cystic fibrosis, and acute respiratory infections are severe respiratory conditions that significantly contribute to global morbidity and mortality. Airway mucus hypersecretion is an important common pathophysiological and clinical manifestation of these diseases and is closely associated with adverse clinical outcomes. At present, the management of airway mucus hypersecretion lacks a viable clinical intervention. However, the revelation that the EGFR signaling pathway acts as a convergent intracellular pathway for many inflammatory mediators indicates that it exhibits the greatest potential for inhibiting excessive mucus production. This review provides a comprehensive overview of the role of EGFR in airway mucus hypersecretion and the therapeutic progress of targeting it, intending to improve clinicians' understanding of the mechanism and offer insights and recommendations for developing novel pharmaceutical interventions to regulate mucus secretion.

30 October 2024 in Respirology
Verified
Journal Article
Closed access
XWXiang Wen
Xiang Wen
JZJuan Zhou
Juan Zhou
HFHeping Fang
Heping Fang
JLJuan Li
Juan Li
RWRun Wang
Run Wang
ELEnmei Liu
Enmei Liu

19 September 2024 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Open access
LLLu Li
Lu Li
XXXiming Xu
Ximing Xu
ELEnmei Liu
Enmei Liu
YDYu Deng
Yu Deng
Background: Airway bacterial microbiota influences the prognosis in children with respiratory syncytial virus infection. The study aimed to investigate the effect of the airway-dominant bacterial microbiota on disease severity in children with pneumonia of respiratory syncytial virus infection. Methods: A retrospective study was conducted in the Children’s Hospital of Chongqing Medical University, which involved a cohort of patients with respiratory syncytial virus (RSV)-infected pneumonia from January 2012 to December 2021. Patients were assigned to a normal flora group or to a dominant flora group (with the top 5 individual bacteria) based on the nasopharyngeal aspirates culture and matched using propensity-score matching. Univariate analysis and multivariate analysis were performed to estimate the risk factors of poor prognosis in dominant flora. Results: Five thousand five hundred and twelve patients in the normal flora and 4556 in the dominant flora were included (Escherichia coli 514, Streptococcus pneumoniae 1516, Staphylococcus aureus 506, Moraxella catarrhalis 509 and Haemophilus influenzae 1516, respectively). The dominant flora had more patients developing severe pneumonia, needing mechanical ventilation/tracheal intubation (up to 15.8% in the S. aureus) and admission to the intensive care unit (up to 4.5% in the E. coli) than in the normal flora (28.5% vs. 25.9%; P = 0.001; 9.8% vs. 5.4%; P < 0.001; 2.0% vs. 1.2%; P <0.001). And the hospitalization was longer in the dominant flora than in the normal flora [8 (6–9) vs. 8 (7–9) days; P < 0.001], the E. coli and S. aureus had the longest hospitalization [8 (7–10) days]. Several factors were associated with critical illness in Dominant flora according to multivariate analysis (P < 0.001), including age (OR: 0.965; CI: 0.954–0.976; P < 0.001), anhelation (OR: 0.530; CI: 0.446–0.631; P < 0.001), disorders of consciousness (OR: 0.055; CI: 0.016–0.185; P < 0.001) as well as assisted respiration (OR: 0.115; CI: 0.097–0.138; P < 0.001), C-reactive protein >10 mg/L (OR: 0.686; CI: 0.560–0.839; P < 0.001), SpO2 <90% (OR: 0.366; CI: 0.214–0.628; P < 0.001), pulmonary consolidation (OR: 0.511; CI: 0.364–0.717; P < 0.001) and pulmonary atelectasis (OR: 0.362; CI: 0.236–0.555; P < 0.001). Conclusions: The airway-dominant bacterial microbiota influenced disease severity and comorbidities in children with RSV-infected pneumonia. Clinicians should pay attention to the nasopharyngeal aspirate culture, especially after detecting S. aureus and E. coli in RSV-infected children with pneumonia, closely observe the disease progression and take timely measures to avoid adverse outcomes.